Lad TE - Search Results

1

Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study.

Shevrin DH, Lad TE, Guinan P, Kilton LJ, Greenburg A, Johnson P, Blough RR, Hoyer H. Shevrin DH, et al. Among authors: lad te. Invest New Drugs. 1994;12(1):65-6. doi: 10.1007/BF00873239. Invest New Drugs. 1994. PMID: 7960609 Clinical Trial. No abstract available.

2

High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial.

Locker GY, Kilton L, Khandekar JD, Lad TE, Knop RH, Albain K, Blough R, French S, Benson AB 3rd. Locker GY, et al. Among authors: lad te. Invest New Drugs. 1994;12(4):299-301. doi: 10.1007/BF00873044. Invest New Drugs. 1994. PMID: 7775130 Clinical Trial.

3

Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study.

Shevrin DH, Kilton LJ, Lad TE, Mullane M, Esparaz B, Knop R, Egner J, Johnson P, Blough R, French S, et al. Shevrin DH, et al. Among authors: lad te. Invest New Drugs. 1994;12(4):345-6. doi: 10.1007/BF00873053. Invest New Drugs. 1994. PMID: 7775139 Clinical Trial. No abstract available.

4

Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: an Illinois Cancer Council Study.

Shevrin DH, Lad TE, Kilton LJ, Cobleigh MA, Blough RR, Weidner LL, Vogelzang NJ. Shevrin DH, et al. Among authors: lad te. Invest New Drugs. 1989 Jul;7(2-3):251-3. doi: 10.1007/BF00170869. Invest New Drugs. 1989. PMID: 2477345

5

Phase II trial of 4' deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.

Rose C, Lad TE, Kilton LJ, Schor J, Rosen ST, Rossof AH, Blough RR, Johnson CM. Rose C, et al. Among authors: lad te. Invest New Drugs. 1990 Feb;8(1):97-9. doi: 10.1007/BF00216932. Invest New Drugs. 1990. PMID: 2160920 Clinical Trial.

6

Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study.

Lad TE, Blough RR, Evrard M, Shevrin DP, Cobleigh MA, Johnson CM, Hange P. Lad TE, et al. Invest New Drugs. 1989 Jul;7(2-3):223-4. doi: 10.1007/BF00170862. Invest New Drugs. 1989. PMID: 2551841

7

Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study.

Rosen F, Vokes EE, Lad T, Kies M, Wade J 3rd, Kilton LJ, Blough R, French S, Mullane M, Benson AB 3rd. Rosen F, et al. Invest New Drugs. 1995;13(3):249-52. doi: 10.1007/BF00873808. Invest New Drugs. 1995. PMID: 8729954 Clinical Trial.

8

Phase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.

Lad T, Schor J, Mullane M, Carroll R, Chernicoff D, Blough R, Weidner L. Lad T, et al. Invest New Drugs. 1992 Apr;10(1):27-8. doi: 10.1007/BF01275475. Invest New Drugs. 1992. PMID: 1318870 Clinical Trial. No abstract available.

9

Phase II trial of aminothiadiazole in advanced non-small cell lung cancer.

Shevrin DH, McGuire WP, Lanzotti V, Krauss S, Blough R, Cobleigh M, Johnson C, Lad T, Kukla L. Shevrin DH, et al. Cancer Treat Rep. 1986 Mar;70(3):417-8. Cancer Treat Rep. 1986. PMID: 3955556 No abstract available.

10

Phase II trial of bisantrene for unresectable non-small cell bronchogenic carcinoma: an Illinois Cancer Council study.

McGuire WP, Blough RR, Cobleigh MA, Johnson CM, Kukla LJ, Lad TE, Lanzotti VJ, Stiff PJ, Zawila P. McGuire WP, et al. Among authors: lad te. Cancer Treat Rep. 1983 Sep;67(9):841-2. Cancer Treat Rep. 1983. PMID: 6883363 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters